Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia
about
Structure of the N-terminal domain of human thioredoxin-interacting proteinThe Emerging Role of Thioredoxin-Interacting Protein in Myocardial Ischemia/Reperfusion InjuryAdenosine-containing molecules amplify glucose signaling and enhance txnip expression.Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell.Crystallization and preliminary X-ray analysis of the N-terminal domain of human thioredoxin-interacting protein.The emerging role of the thioredoxin system in angiogenesisDeoxyribozymes: new therapeutics to treat central nervous system disordersA novel role of myosin VI in human prostate cancerThioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus.Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injuryPathogenesis of aortic stenosis: not just a matter of wear and tearEarly-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes.Calcium channel blockers act through nuclear factor Y to control transcription of key cardiac genes.Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart DefectsThioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.A bimodal association of vitamin D levels and vascular disease in children on dialysisHECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.Expression, localization, and function of the thioredoxin system in diabetic nephropathy.DNAzymes and cardiovascular disease.Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting proteinSelective inhibition of the master regulator transcription factor Egr-1 with catalytic oligonucleotides reduces myocardial injury and improves left ventricular systolic function in a preclinical model of myocardial infarctionTranscription factors Krüppel-like factor 6 and peroxisome proliferator-activated receptor-{gamma} mediate high glucose-induced thioredoxin-interacting protein.Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms.Thioredoxin-interacting protein and myocardial mitochondrial function in ischemia-reperfusion injury.Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes.Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia.The vitamin D analogue paricalcitol attenuates hepatic ischemia/reperfusion injury through down-regulation of Toll-like receptor 4 signaling in rats.Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.Melatonin rescues cardiac thioredoxin system during ischemia-reperfusion injury in acute hyperglycemic state by restoring Notch1/Hes1/Akt signaling in a membrane receptor-dependent manner.Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.The Role of Parathyroid Hormone and Vitamin D Serum Concentrations in Patients with Cardiovascular Diseases.
P2860
Q27684226-462657E6-214E-4B87-BDCE-3F7F564AC7AFQ33559046-434F701B-9697-4408-A745-B4CEF99AEB60Q33642473-F79772D7-8558-4D09-9A93-80AAF4FE10C6Q33977405-9944EB60-FEBD-4377-8981-23ADD3FA1F30Q34925688-D9298462-9E32-4CDC-97A9-283819A2FB03Q35123800-151212C9-4170-4E08-BDD1-A773C8894B95Q35228538-65C29039-A6F9-4834-B02E-24E78557333AQ35607414-B0954E71-B420-41D6-9D91-73056654701BQ35634417-98144FC9-2AA9-4F96-9904-0742A9144AD1Q35640549-00F55766-8705-45FB-9B64-D7994A6E3696Q35660101-E6F7D7DA-4881-4354-8972-C892C2E6EF8FQ36109260-17BD7E5A-A46B-4394-9F1F-E9DA8D99C70FQ36174757-8AB3B4AF-1C7D-4DF6-8AB2-BE4E707E6056Q36587094-0EFE0298-08D3-44A6-9E00-E24A8B000750Q36629722-31DE129A-01AA-41EB-8119-C0561F63565AQ36677652-1B540AFB-8058-4FCF-9294-33C2444E664CQ36877602-5F9C1FF8-292C-4617-B8F8-166336D15B31Q36918516-AC43CFC9-C0DA-48EA-9687-A3F353F71275Q37146420-4FE85B96-A021-44CB-BFA6-7E75D24E97B2Q37153589-A7FE9EAB-4301-4430-BF3A-230BEDF8B1ABQ37190118-4893B8DA-1695-40A0-98F7-1CC2E7B197B7Q37310415-6363B431-BB86-4D70-923D-C4BA19D7D8E7Q37413641-89C7A20E-F280-4E7D-BCA2-A1D9B46E33D7Q37935006-AC3EF3EC-3FD0-4CE7-80FA-E30EC8CB6A24Q38124617-7C65B3FD-CBC4-49B2-84BB-C7BB93367147Q38236593-582F359C-6858-4577-805A-4CD034CC7473Q38378692-6CBC24B0-5E66-4159-9FC2-7E61C40E8FF0Q41436449-CDC78604-E0CF-418F-AC88-C1DA6D3C31E3Q41956279-79142D2D-0532-4291-ABE1-B70B7F6C7B7AQ46880204-48C5CA15-5949-4C31-95D7-069802966B24Q51135089-AC814DCA-1627-4100-8C35-B59E868DC3B3Q52709221-FB7B4376-C9BE-4ED9-AE24-8E23A8A5737EQ54513464-09C907A8-61EE-4EF8-A224-A8530253F87CQ55447721-E7D4AF8D-204A-4754-9195-CEB33B24F26C
P2860
Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia
description
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2005
@ast
im November 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/11/25)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/11/25)
@nl
наукова стаття, опублікована в листопаді 2005
@uk
name
Catalytic degradation of vitam ...... ling after myocardial ischemia
@ast
Catalytic degradation of vitam ...... ling after myocardial ischemia
@en
Catalytic degradation of vitam ...... ling after myocardial ischemia
@nl
type
label
Catalytic degradation of vitam ...... ling after myocardial ischemia
@ast
Catalytic degradation of vitam ...... ling after myocardial ischemia
@en
Catalytic degradation of vitam ...... ling after myocardial ischemia
@nl
prefLabel
Catalytic degradation of vitam ...... ling after myocardial ischemia
@ast
Catalytic degradation of vitam ...... ling after myocardial ischemia
@en
Catalytic degradation of vitam ...... ling after myocardial ischemia
@nl
P2093
P2860
P3181
P356
P1476
Catalytic degradation of vitam ...... ling after myocardial ischemia
@en
P2093
Alfred Kocher
Andrew J. Boyle
Guosheng Xiang
Hugo Sondermeijer
Michael D. Schuster
Piotr Witkowski
Silviu Itescu
Tetsunori Seki
Timothy P. Martens
P2860
P304
39394–39402
P3181
P356
10.1074/JBC.M502966200
P407
P50
P577
2005-11-25T00:00:00Z